NCT01233570View on ClinicalTrials.gov

Topical Tacrolimus 0.1% Ointment For Treatment Of Cutaneous Crohn's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

Not specified

Conditions
Crohn Disease
Interventions
DRUG

Tacrolimus

Once daily application for 12 weeks followed by 4 weeks observation. Optional 36 week open label extension

Trial Locations (1)

AB25 2ZN

University of Aberdeen, Aberdeen Royal Infirmary, Aberdeen

All Listed Sponsors
lead

University of Aberdeen

OTHER

NCT01233570 - Topical Tacrolimus 0.1% Ointment For Treatment Of Cutaneous Crohn's Disease | Biotech Hunter | Biotech Hunter